Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Oct 2026 for BridgeBio Oncology Therapeutics, Inc., €484.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Marc Cobo: trading record in brief
Marc Cobo is a declared insider at 2 companies; the most frequent names are BridgeBio Oncology Therapeutics, Inc. and Tricida, Inc. Over a trading history stretching from 10 September 2020 to 21 October 2026, the count stands at 6 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 23 October 2026, reports a share grant of €484 in BridgeBio Oncology Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Marc Cobo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
203 shares@ US$2.68Common StockSEC:0001193125-26-430449:0
126 shares@ US$3.940.0002% mcap19.4% of flowCommon StockSEC:0001193125-26-414135:0
9,038 shares0Common StockSEC:0001193125-26-390624:0
203 shares@ US$5.520.0005% mcap42.7% of flowCommon StockSEC:0001193125-26-390624:1
125 shares@ US$7.800.0003% mcap47.1% of flowCommon StockSEC:0001193125-26-296504:0
3,000 shares0Common StockSEC:0001595585-20-000125:0
6 of 6 declarations
